featured
Palbociclib in Combination With Endocrine Therapy for HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER− Advanced Breast Cancer
J. Natl. Cancer Inst 2018 Jul 18;[EPub Ahead of Print], V Diéras, HS Rugo, P Schnell, K Gelmon, M Cristofanilli, S Loi, M Colleoni, DR Lu, A Mori, E Gauthier, C Huang Bartlett, DJ Slamon, NC Turner, RS FinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.